PREVISCAN Side Effects

6147473-4 | Fall, Pubic Rami Fracture, Traumatic Brain Injury
on Mar 27, 2009 Female patient from FRANCE , 89 years of age, was treated with Previscan (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), pubic rami fracture, traumatic brain injury (What is traumatic brain injury?). Previscan dosage: . During the same period patient was treated with COVERSYL 2 MG TABLET (Daily Dose: 2 Milligram(s)) (View Coversyl 2 Mg Tablet Review and Coversyl 2 Mg Tablet Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), DIFFU K (View Diffu K Review and Diffu K Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

5906259-3 | Confusional State, Hypoglycaemia, Renal Failure, Urinary Tract Infection
Patient was taking Previscan (View Usage). Patient had the following side effects: confusional state, hypoglycaemia, renal failure, urinary tract infection (What is urinary tract infection?) on Sep 16, 2008 from FRANCE Additional patient health information: Female patient , 84 years of age, was diagnosed with hypertension, type 2 diabetes mellitus, arrhythmia supraventricular and. Previscan dosage: . During the same period patient was treated with COVERSYL (Daily Dose: 2 Milligram(s)) (View Coversyl Review and Coversyl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DIAMICRON (Daily Dose: 30 Milligram(s)) (View Diamicron Review and Diamicron Label ), LASIX (View Lasix Review and Lasix Label ), ACTOS (Daily Dose: 30 Milligram(s)) (View Actos Review and Actos Label ), IMOVANE (View Imovane Review and Imovane Label ), TENORMIN (Daily Dose: 100 Milligram(s)) (View Tenormin Review and Tenormin Label ), KALEORID (View Kaleorid Review and Kaleorid Label ). Patient was hospitalized.

5733804-3 | Faeces Discoloured
Adverse event was reported on Apr 28, 2008 by a Male patient taking Previscan (View Usage) (Dosage: Unk) was diagnosed with diabetes mellitus and. Location: FRANCE , 83 years of age, After Previscan was administered, patient had the following side effects: faeces discoloured. During the same period patient was treated with NEXIUM (Unk) (View Nexium Review and Nexium Label ), INSULIN (Unk) (View Insulin Review and Insulin Label ), KAYEXALATE (View Kayexalate Review and Kayexalate Label ), TARDYFERON (Unk) (View Tardyferon Review and Tardyferon Label ).

5703733-X | Anaemia, Haematoma, International Normalised Ratio Increased, Pain In Extremity, Prothrombin Time Ratio Decreased
on Apr 04, 2008 Male patient from FRANCE , 58 years of age, was treated with Previscan (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, haematoma, international normalised ratio increased, pain in extremity, prothrombin time ratio decreased. Previscan dosage: 0.5 Df, Qd. During the same period patient was treated with CORDARONE (View Cordarone Review and Cordarone Label ), LASILIX (View Lasilix Review and Lasilix Label ), LESCOL (View Lescol Review and Lescol Label ), KENZEN (View Kenzen Review and Kenzen Label ). Patient was hospitalized.


5604675-0 | Ecthyma, Pruritus
on Jan 15, 2008 Female patient from FRANCE , 81 years of age, was diagnosed with ill-defined disorder, angina pectoris and was treated with Previscan (View Usage). Patient had the following side effects: ecthyma, pruritus. Previscan dosage: . During the same period patient was treated with COVERSYL (Daily Dose: 2 Milligram(s)) (View Coversyl Review and Coversyl Label ), LASIX (View Lasix Review and Lasix Label ), VASTEN (View Vasten Review and Vasten Label ), MOPRAL (View Mopral Review and Mopral Label ), DIFFU K (View Diffu K Review and Diffu K Label ), SINGULAIR (View Singulair Review and Singulair Label ), SERETIDE (View Seretide Review and Seretide Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ). Patient was hospitalized.

5568361-8 | Electrocardiogram Abnormal, Pleural Effusion, Pulmonary Hypertension
Patient was taking Previscan (View Usage). After Previscan was administered, patient had the following side effects: electrocardiogram abnormal, pleural effusion, pulmonary hypertension (What is pulmonary hypertension?) on Dec 13, 2007 from FRANCE Additional patient health information: Male patient , 85 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), chronic myeloid leukaemia and. Previscan dosage: . During the same period patient was treated with GLEEVEC (400 Mg, Qd) (View Gleevec Review and Gleevec Label ). Patient was hospitalized.

5517580-5 | Melaena
Adverse event was reported on Nov 02, 2007 by a Male patient taking Previscan (View Usage) (Dosage: Unk) was diagnosed with diabetes mellitus and. Location: FRANCE , 83 years of age, Patient experienced the following unwanted or unexpected effects: melaena. During the same period patient was treated with INEXIUM (Unk) (View Inexium Review and Inexium Label ), INSULIN (Unk) (View Insulin Review and Insulin Label ), KAYEXALATE (View Kayexalate Review and Kayexalate Label ).

5456589-7 | Cerebral Haematoma, Phlebitis
on Sep 06, 2007 Male patient from FRANCE , 77 years of age, was diagnosed with phlebitis, aortic aneurysm (What is aortic aneurysm?) and was treated with Previscan (View Usage). Patient had the following side effects: cerebral haematoma, phlebitis. Previscan dosage: Unk. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ).

5378779-4 | Coagulation Time Prolonged, Intentional Overdose, Loss Of Consciousness
on Jun 22, 2007 Female patient from FRANCE , 57 years of age, was diagnosed with mitral valve disease, depression (What is depression?), intentional overdose and was treated with Previscan (View Usage). After Previscan was administered, patient had the following side effects: coagulation time prolonged, intentional overdose, loss of consciousness. Previscan dosage: . During the same period patient was treated with EFFEXOR (View Effexor Review and Effexor Label ), CORDARONE (View Cordarone Review and Cordarone Label ), MEPRONIZINE (View Mepronizine Review and Mepronizine Label ), TRANXENE (View Tranxene Review and Tranxene Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ). Patient was hospitalized.

5365750-1 | Rectal Haemorrhage, Septic Shock
Patient was taking Previscan (View Usage). Patient experienced the following unwanted or unexpected effects: rectal haemorrhage, septic shock on Jun 14, 2007 from FRANCE Additional patient health information: Male patient , weighting 207.2 lb, was diagnosed with pancreatic carcinoma metastatic and. Previscan dosage: . During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), FLUOROURACIL (800 Mg Bolus Followed By 4800 Mg Infusion) (View Fluorouracil Review and Fluorouracil Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), AVK (View Avk Review and Avk Label ). Patient was hospitalized.

5349336-0 | Rectal Haemorrhage, Septic Shock
Adverse event was reported on Jun 04, 2007 by a Male patient taking Previscan (View Usage) (Dosage: ) was diagnosed with pancreatic carcinoma metastatic and. Location: FRANCE , weighting 207.2 lb, Patient had the following side effects: rectal haemorrhage, septic shock. During the same period patient was treated with FLUOROURACIL (800 Mg Bolus Followed By 4800 Mg Infusion) (View Fluorouracil Review and Fluorouracil Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

5333701-1 | Blood Fibrinogen Decreased, International Normalised Ratio Abnormal, Prothrombin Level Abnormal
on May 07, 2007 Female patient from FRANCE , child 3 years of age, weighting 26.46 lb, was treated with Previscan (View Usage). After Previscan was administered, patient had the following side effects: blood fibrinogen decreased, international normalised ratio abnormal, prothrombin level abnormal. Previscan dosage: 2mg Per Day. During the same period patient was treated with CLAMOXYL (View Clamoxyl Review and Clamoxyl Label ), FERROSTRANE (View Ferrostrane Review and Ferrostrane Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), TIORFAN (View Tiorfan Review and Tiorfan Label ), FLAGYL (View Flagyl Review and Flagyl Label ), CODENFAN (View Codenfan Review and Codenfan Label ), FOLDINE (View Foldine Review and Foldine Label ), LACTEOL (View Lacteol Review and Lacteol Label ). Patient was hospitalized.

5318679-9 | Rectal Haemorrhage, Septic Shock
on May 02, 2007 Male patient from FRANCE , weighting 207.2 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Previscan (View Usage). Patient experienced the following unwanted or unexpected effects: rectal haemorrhage, septic shock. Previscan dosage: . During the same period patient was treated with FLUOROURACIL (800 Mg Bolus Followed By 4800 Mg Infusion) (View Fluorouracil Review and Fluorouracil Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

5182905-X | Blood Alkaline Phosphatase Increased, C-reactive Protein Increased, Dermatitis Exfoliative, Eosinophilia, Erythema, Renal Failure Acute
Patient was taking Previscan (View Usage). Patient had the following side effects: blood alkaline phosphatase increased, c-reactive protein increased, dermatitis exfoliative, eosinophilia, erythema, renal failure acute on Dec 04, 2006 from FRANCE Additional patient health information: Female patient , 80 years of age, was diagnosed with gouty arthritis and. Previscan dosage: Unk. During the same period patient was treated with ZOLPIDEM TARTRATE (Unk) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TRIATEC (View Triatec Review and Triatec Label ), DIAMICRON (Unk) (View Diamicron Review and Diamicron Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), LASIX (View Lasix Review and Lasix Label ), FASTURTEC (View Fasturtec Review and Fasturtec Label ). Patient was hospitalized.

5114203-4 | Ascites, Granulomatous Liver Disease, Hepatic Enzyme Abnormal
Adverse event was reported on Sep 15, 2006 by a Male patient taking Previscan (View Usage) (Dosage: Unk) was diagnosed with thrombosis, dental care, diarrhoea and. Location: FRANCE , 40 years of age, After Previscan was administered, patient had the following side effects: ascites, granulomatous liver disease, hepatic enzyme abnormal. During the same period patient was treated with NEXIUM (Unk) (View Nexium Review and Nexium Label ), AVLOCARDYL (Unk) (View Avlocardyl Review and Avlocardyl Label ), PLAVIX (View Plavix Review and Plavix Label ), SMECTA (Unk) (View Smecta Review and Smecta Label ). Patient was hospitalized.

4784925-3 | Cerebral Haemorrhage, Chills, Csf Shunt Operation, Difficulty In Walking, Hepatic Failure, Hydrocephalus, Hyperthermia Malignant, Nervous System Disorder, Renal Failure
on Sep 26, 2005 Male patient from FRANCE , 23 years of age, was treated with Previscan (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, chills, csf shunt operation, difficulty in walking, hepatic failure, hydrocephalus (What is hydrocephalus?), hyperthermia malignant, nervous system disorder, renal failure. Previscan dosage: 20 Mg, Qd. During the same period patient was treated with TRILEPTAL (300 Mg, Unk) (View Trileptal Review and Trileptal Label ). Patient was hospitalized.

4784925-3 | Cerebral Haemorrhage, Chills, Csf Shunt Operation, Difficulty In Walking, Hepatic Failure, Hydrocephalus, Hyperthermia Malignant, Nervous System Disorder, Renal Failure
on Sep 26, 2005 Male patient from FRANCE , 23 years of age, was treated with Previscan (View Usage). Patient had the following side effects: cerebral haemorrhage, chills, csf shunt operation, difficulty in walking, hepatic failure, hydrocephalus (What is hydrocephalus?), hyperthermia malignant, nervous system disorder, renal failure. Previscan dosage: 20 Mg, Qd. During the same period patient was treated with TRILEPTAL (300 Mg, Unk) (View Trileptal Review and Trileptal Label ). Patient was hospitalized.

4736181-X | Haematuria
Patient was taking Previscan (View Usage). After Previscan was administered, patient had the following side effects: haematuria on Jul 08, 2005 from FRANCE Additional patient health information: Male patient , 68 years of age, weighting 158.7 lb, was diagnosed with nail tinea and. Previscan dosage: 1 Df, Qd. During the same period patient was treated with LAMISIL (250 Mg, Qd) (View Lamisil Review and Lamisil Label ), DIAMICRON (2 Df, Qd) (View Diamicron Review and Diamicron Label ), METFORMIN HCL (3 Df Daily) (View Metformin Hcl Review and Metformin Hcl Label ).

4648587-8 | Agranulocytosis, Petechiae, Vascular Purpura
Adverse event was reported on Apr 22, 2005 by a Male patient taking Previscan (View Usage) (Dosage: ) was diagnosed with atrial fibrillation (What is atrial fibrillation?), dementia (What is dementia?), agitation and. Location: , 84 years of age, Patient experienced the following unwanted or unexpected effects: agranulocytosis, petechiae, vascular purpura. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), EXELON (1.5 Mg, Bid) (View Exelon Review and Exelon Label ), SERESTA (View Seresta Review and Seresta Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), PROZAC (View Prozac Review and Prozac Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), EQUANIL (Prn) (View Equanil Review and Equanil Label ). Patient was hospitalized.

4622810-8 | Abdominal Pain, Abnormal Faeces, Colitis Ulcerative, Defaecation Urgency, Diarrhoea Haemorrhagic, Microcytic Anaemia, Weight Decreased
on Mar 22, 2005 Female patient from , 13 years of age, was diagnosed with lower limb fracture and was treated with Previscan (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), abnormal faeces, colitis ulcerative, defaecation urgency, diarrhoea haemorrhagic, microcytic anaemia, weight decreased. Previscan dosage: . During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), PROFENID (View Profenid Review and Profenid Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

4621880-0 | Atrioventricular Block Complete, Bradycardia, Dialysis, Hyperkalaemia, Hyperphosphataemia, Hyponatraemia, Metabolic Acidosis, Renal Failure Acute
on Mar 18, 2005 Male patient from , 81 years of age, was diagnosed with ill-defined disorder, cardiac failure and was treated with Previscan (View Usage). After Previscan was administered, patient had the following side effects: atrioventricular block complete, bradycardia, dialysis (What is dialysis?), hyperkalaemia, hyperphosphataemia, hyponatraemia, metabolic acidosis, renal failure acute. Previscan dosage: . During the same period patient was treated with COVERSYL (Daily Dose: 4 Milligram(s)) (View Coversyl Review and Coversyl Label ), ALDACTONE (Daily Dose: 25 Milligram(s)) (View Aldactone Review and Aldactone Label ), TAHOR (View Tahor Review and Tahor Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ATHYMIL (View Athymil Review and Athymil Label ), TERCIAN (View Tercian Review and Tercian Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).